Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Levered Free Cash Flow (FCF)

Arbutus Biopharma Cp Levered Free Cash Flow (FCF) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2018.
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the last 12 months ending December 12, 2018 was $-49m a 51.34% decrease of -25m year over year
  • Arbutus Biopharma Cp Annual Levered Free Cash Flow (FCF) for 2018 was $-49m a 34.85% decrease of -17m from 2017
  • Arbutus Biopharma Cp Annual Levered Free Cash Flow (FCF) for 2017 was $-32m a 81.84% decrease of -26m from 2016
  • Arbutus Biopharma Cp Annual Levered Free Cash Flow (FCF) for 2016 was $-6m a -232.84% increase of 14m from 2015
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Levered Free Cash Flow (FCF) Data

12/2018$-36m
09/2018$-7m
06/2018$-12m
03/2018$-13m
12/2017$-7m
09/2017$-7m
06/2017$-2m
03/2017$-18m
12/2016$-7m
09/2016$-6m

Annual ABUS Levered Free Cash Flow (FCF) Data

2018$-49m
2017$-32m
2016$-6m
2015$-19m
2014$-13m
2013$-3m
2012$-4m
2011$-3m
2010$-6m
2009$-4m